SELCUK UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF HEMATOLOGY -Turkey
AUTHOR PROFILE
Scopus
Orcid
Google Scholar
EARLY ACADEMIC PURSUITS:
Rafıye Ciftciler embarked on her academic journey with a strong foundation in medicine and a focus on hematology. She pursued her Medical School education at Hacettepe University Faculty of Medicine, where she laid the groundwork for her future contributions to the field.
PROFESSIONAL ENDEAVORS:
Following her medical education, Rafıye Ciftciler delved into Internal Medicine at Gazi University Faculty of Medicine, broadening her clinical expertise. Subsequently, she specialized in Hematology at Hacettepe University Faculty of Medicine, honing her skills in the intricate field of blood disorders.
Rafıye Ciftciler has significantly contributed to the science of hematology, with approximately 100 publications to her name. Her research encompasses a diverse range of topics within hematology, showcasing her dedication to advancing knowledge in the field.
IMPACT AND INFLUENCE:
Her impact extends beyond publications, as evidenced by her accolades. The Young Researcher Award from the Turkish Society of Hematology at the 44th National Hematology Congress and the Oral Presentation Award at the 3rd National Blood and Bone Marrow Transplant Congress underscore her influence in the academic and scientific community.
ACADEMIC CITES:
Rafıye Ciftciler's work has likely garnered attention within the academic community, reflected in her certifications from esteemed organizations like the European Hematology Association and the Turkish Hematology Association. These certifications affirm her proficiency and recognition in the broader scientific arena.
LEGACY AND FUTURE CONTRIBUTIONS:
As an Associate Professor in the Department of Hematology at Selcuk University Faculty of Medicine, Rafıye Ciftciler has already established a commendable legacy. Her continuous contributions to the science of hematology and her role in shaping the next generation of medical professionals mark her as a key figure in the field.
HIGHLIGHT OF FUTURE CONTRIBUTIONS:
Looking ahead, Rafıye Ciftciler's future contributions are anticipated to further enrich the field of Targeted Cancer Therapy. Whether through groundbreaking research, mentorship, or educational initiatives, her commitment to advancing knowledge and improving patient care is poised to leave a lasting impact on the discipline.
NOTABLE PUBLICATIONS
Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic Malignancies. 2024
The Effect of Obesity and Body Mass Index on Hematologic Malignancies. 2023
Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report. 2023
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia. 2023
Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores. 2023